NZ follows TGA rule change

Posted 19 June 2025 PM

It’s been almost two years since the TGA relaxed rules around psychedelic drugs, with New Zealand’s Medsafe following suit and approving the use of psilocybin for patients with treatment-resistant depression outside clinical trials.

Psilocybin (the active ingredient in magic mushrooms) will still be an unapproved medicine but will be able to be granted under the authority of one specific highly experienced psychiatrist, Dr Cameron Lacey.

To see the whole article, please login